PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1096285

[Rheumatoid synovial fluid].

C F Roques·M Blanc·M Abbal·J Pradère·M Courtin·H Amigues·A Gournié·R Ruffié
View original source ↗Export metadata ↓

Abstract

In making a comparative study of different parameters in the examination of synovial fluid (rheumatoid factors, ragocytes, leucocytes, synovial complement, immunoglobulins) the authors show that rheumatoid fluid has characteristics that make differentiation from other inflammatory arthropathies possible on a statistical basis, thanks to the test for the homogeneity of the means. The presence of these characteristics seems to constitute a diagnostic argument which can be measured by mathematical methods.

Explore related subjects

ArthritisArthritis, RheumatoidClinical Trials as TopicComplement System ProteinsDiagnosis, DifferentialHemagglutination TestsHumansImmunoglobulinsLatex Fixation TestsLeukocyte CountRheumatic DiseasesRheumatoid FactorSynovial FluidClinical TrialComparative StudyEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C F Roques, M Blanc, M Abbal, J Pradère, M Courtin, H Amigues, A Gournié, R Ruffié. 1975. [Rheumatoid synovial fluid].. https://pubmed.ncbi.nlm.nih.gov/1096285/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Interleukin-18 genetics and inflammatory disease susceptibility.

IL18 was mapped to 11q22.2-22.3 in 1998. Owing to interleukin (IL)-18's important and novel role in immunomodulation, the gene itself has been subject to scrutiny, with the aim of discovering variants that may impact on disease susceptibility and/or progression. Despite being sequenced numerous times in different populations, no non-synonymous variants have been found. However, a number of polymorphisms within the proximal promoter have been verified that may interfere with transcription-factor-binding sites. Much of the subsequent association analyses have centred on these variants, but have yielded no consistent results, despite numerous different study populations being genotyped. IL18 has recently been resequenced in its entirety, enabling the tagging-single-nucleotide polymorphism (tSNP) methodology to be adopted. This approach has yielded interesting results, with genetic variation being shown to affect protein levels, and risk. This review aims to compile and reflect on the association data of interest published to date, with a focus on the diseases related to aberrant inflammatory control.

Arthritis↗